cde.news
Testing of CanSino’s COVID-19 candidate vaccine begins in Russia
A late-stage trial of a COVID-19 candidate vaccine from CanSino Biologics Inc has started in Russia, registration records showed, as the Chinese pharmaceutical
Cde
